This finding, together with the observation that c-Met KD mutant abrogates HHLA2-driven tumor promotion in HDTVi HCC mouse models (Fig. 4G), strongly supports the necessity of functional c-Met and its kinase activity for HHLA2-dependent Erk activation. This evidence concerns the gene MET and hepatocellular carcinoma.